Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

31126
1
Oblong, Inc. Oblong, Inc. Reports Significant Financial Challenges in Q3 2024, Sees Revenue Decline and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

31127
1
Tourmaline Bio, Inc. Tourmaline Bio Reports Significant Financial Developments, Raises $172.5 Million in Public Offering

Via official filing (AI summary) | over 1 year ago | 0 comments

31128
1
Aptevo Therapeutics Inc. Aptevo Therapeutics Reports Significant Financial Challenges, Net Loss, and Cash Decline in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

31129
1
PepGen Inc. PepGen Inc. Reports Financial Update, Advances Clinical Pipeline Despite Ongoing Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

31130
1
International Seaways, Inc. International Seaways Reports Decline in Revenues and Profitability for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31131
1
Acadian Asset Management Inc. BrightSphere Investment Group Reports Mixed Q3 Results, Revenue Growth, and Strategic Developments

Via official filing (AI summary) | over 1 year ago | 0 comments

31132
1
Priority Technology Holdings, Inc. Priority Technology Holdings Reports 20.1% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31133
1
STERIS plc Steris Reports 7.3% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31134
1
PMV Pharmaceuticals, Inc. PMV Pharmaceuticals Reports Q3 Financial Results, Net Loss Improves Despite Increased R&D Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments

31135
1
iHeartMedia, Inc. iHeartMedia Reports Mixed Q3 2024 Results with Revenue Growth and Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

31136
1
Sunrise Realty Trust, Inc. Sunrise Realty Trust Reports Significant Financial Growth Following Spin-Off from Advanced Flower Capital Inc.

Via official filing (AI summary) | over 1 year ago | 0 comments

31137
1
HilleVax, Inc. HilleVax Reports Decrease in Cash and Cash Equivalents, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31138
1
MESA LABORATORIES INC /CO/ Mesa Laboratories Reports 8.8% Revenue Growth, Turnaround in Operating Income and Net Income for Q3 and H1 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31139
1
ACORN ENERGY, INC. Acorn Energy Reports 28% Revenue Growth, Turnaround in Operating Income and Net Income for Nine Months Ended September 30, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31140
1
VERACYTE, INC. Veracyte Reports 29% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31141
1
Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Reports 23% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31142
1
AMEDISYS INC Amedisys Reports Revenue Growth, Decline in Profitability in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31143
1
ImageneBio, Inc. Ikena Oncology Reports Significant Financial Changes, Decline in Cash and Cash Equivalents in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31144
1
RADIAN GROUP INC Radian Group Reports Mixed Q3 Results, Net Investment Income Drives Growth

Via official filing (AI summary) | over 1 year ago | 0 comments

31145
1
NORTECH SYSTEMS INC Nortech Systems Reports Decline in Net Sales and Gross Profit for Q3 and Nine Months of Fiscal 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31146
1
Jazz Pharmaceuticals plc Jazz Pharmaceuticals Reports 9% Revenue Growth in Q3 2024, Net Income Up 46%

Via official filing (AI summary) | over 1 year ago | 0 comments

31147
1
Angel Oak Mortgage REIT, Inc. Angel Oak Mortgage REIT Reports Increased Net Income and Strong Liquidity in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31148
1
Carisma Therapeutics Inc. Carisma Therapeutics Reports Significant Financial Decline, Uncertainty Over Future Funding

Via official filing (AI summary) | over 1 year ago | 0 comments

31149
1
Cingulate Inc. Cingulate Inc. Reports Improved Financials, Reduced Losses in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31150
1
Walker & Dunlop, Inc. Walker & Dunlop Reports 9% Revenue Growth, 34% Increase in Net Income for Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments